Robert Lakin

Robert Lakin

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today

Ocugen's Indian vaccine development partner reported better-than-expected results from its local Covid-19 vaccine trials. OCGN stock has been on a roller-coaster ride on every Covaxin rumor and news item.

DNUT Stock: What to Know as Krispy Kreme Starts Trading Today

From your waistline to the bottom line, Krispy Kreme is back on Wall Street. The IPO priced below expectations as DNUT stock is set to debut today.

Chinese EV Stocks: Why LI, XPEV, NIO Stocks Are Revving Up Today

Chinese EV makers are reporting record deliveries for June and Q2 despite a chip shortage. Nio and Xpeng both reported triple-digit percentage increases in units delivered.

SRAC Stock: Why Stable Road Is Gaining Ahead of a Momentus SPAC Merger

SPAC sponsor Stable Road Acquisition is getting more time to complete the SRAC stock merger with space cargo hauler Momentus.

XELA Stock: The Big News That Has Exela Technologies Continuing to Soar

XELA stock is up another 50% in Wednesday morning trading as Exela benefits from short-squeeze hopes and company updates.